Target Healthcare REIT (LON:THRL – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as GBX 99 ($1.32) and last traded at GBX 98.60 ($1.32), with a volume of 192688 shares. The stock had previously closed at GBX 98.30 ($1.32).
Target Healthcare REIT Stock Down 0.1 %
The firm has a fifty day moving average of GBX 90.10 and a 200 day moving average of GBX 87.02. The stock has a market cap of £601.09 million, a PE ratio of 8.23, a price-to-earnings-growth ratio of 1.48 and a beta of 0.44. The company has a quick ratio of 1.52, a current ratio of 7.20 and a debt-to-equity ratio of 34.92.
Target Healthcare REIT (LON:THRL – Get Free Report) last announced its earnings results on Friday, March 14th. The company reported GBX 3.06 ($0.04) earnings per share (EPS) for the quarter. Target Healthcare REIT had a net margin of 104.99% and a return on equity of 10.78%. On average, equities research analysts anticipate that Target Healthcare REIT will post 6.2219101 EPS for the current fiscal year.
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Recommended Stories
- Five stocks we like better than Target Healthcare REIT
- Why Are Stock Sectors Important to Successful Investing?
- Cellectis Charts Course for 2025 With Boost From AstraZeneca Deal
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Netflix Is the “Cleanest Story in Tech”
- Canada Bond Market Holiday: How to Invest and Trade
- UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.